Washington Trust CO Biomarin Pharmaceutical Inc Transaction History

Washington Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$71.48 - $86.85 $2,430 - $2,952	-34 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$74.28 - $92.69 $4,233 - $5,283	-57 Reduced 62.64%	34 $3,000
Q4 2021 Feb 09, 2022	BUY	$71.72 - $91.47 $143 - $182	2 Added 2.25%	91 $8,000
Q3 2020 Nov 05, 2020	BUY	$71.87 - $131.03 $862 - $1,572	12 Added 15.58%	89 $7,000
Q2 2020 Aug 04, 2020	SELL	$79.55 - $124.22 $1,909 - $2,981	-24 Reduced 23.76%	77 $9,000
Q1 2020 May 07, 2020	BUY	$71.37 - $96.85 $7,208 - $9,781	101 New	101 $9,000
Q3 2018 Nov 13, 2018	SELL	$93.92 - $105.72 $3,662 - $4,123	-39 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$76.01 - $99.03 $2,964 - $3,862	39 New	39 $4,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

Stay updated on Washington Trust CO with notifications on news.